S&P 500   3,941.48
DOW   31,928.62
QQQ   287.24
S&P 500   3,941.48
DOW   31,928.62
QQQ   287.24
S&P 500   3,941.48
DOW   31,928.62
QQQ   287.24
S&P 500   3,941.48
DOW   31,928.62
QQQ   287.24

AMERISAFE (AMSF) Stock Forecast, Price & News

+0.45 (+0.94%)
(As of 05/24/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
164,764 shs
Average Volume
104,454 shs
Market Capitalization
$937.21 million
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive AMSF News and Ratings via Email

Sign-up to receive the latest news and ratings for AMERISAFE and its competitors with MarketBeat's FREE daily newsletter.



AMERISAFE, Inc., an insurance holding company, underwrites workers' compensation insurance in the United States. The company's workers' compensation insurance policies provide benefits to injured employees for temporary or permanent disability, death, and medical and hospital expenses. It serves small to mid-sized employers engaged in hazardous industries, including construction, trucking, logging and lumber, agriculture, manufacturing, telecommunications, and maritime. The company was incorporated in 1985 and is based in DeRidder, Louisiana.


See More Headlines

Industry, Sector and Symbol

Fire, marine, & casualty insurance
Property & Casualty Insurance
Current Symbol
Year Founded

Sales & Book Value

Annual Sales
$315.93 million
Cash Flow
$3.38 per share
Book Value
$20.46 per share


Net Income
$65.76 million
Pretax Margin




Free Float
Market Cap
$937.21 million

Company Calendar

Ex-Dividend for 3/25 Dividend
Dividend Payable
Last Earnings
Ex-Dividend for 6/24 Dividend
Dividend Payable
Next Earnings (Estimated)
Fiscal Year End

Social Links


Overall MarketRank

2.42 out of 5 stars

Finance Sector

494th out of 1,379 stocks

Fire, Marine, & Casualty Insurance Industry

29th out of 73 stocks

Analyst Opinion: 2.3Community Rank: 4.0Dividend Strength: 3.3Insider Behavior: 2.5Valuation: 0.0 5 -4 -3 -2 -1 -

AMERISAFE (NASDAQ:AMSF) Frequently Asked Questions

Is AMERISAFE a buy right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AMERISAFE in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" AMERISAFE stock.
View analyst ratings for AMERISAFE
or view top-rated stocks.

When is AMERISAFE's next earnings date?

AMERISAFE is scheduled to release its next quarterly earnings announcement on Wednesday, July 27th 2022.
View our earnings forecast for AMERISAFE

How were AMERISAFE's earnings last quarter?

AMERISAFE, Inc. (NASDAQ:AMSF) announced its quarterly earnings data on Wednesday, April, 27th. The insurance provider reported $0.82 earnings per share for the quarter, topping the consensus estimate of $0.61 by $0.21. The insurance provider earned $73.78 million during the quarter, compared to analyst estimates of $72 million. AMERISAFE had a net margin of 20.70% and a trailing twelve-month return on equity of 12.83%. During the same quarter last year, the business posted $0.76 EPS.
View AMERISAFE's earnings history

How often does AMERISAFE pay dividends? What is the dividend yield for AMERISAFE?

AMERISAFE declared a quarterly dividend on Tuesday, April 26th. Stockholders of record on Friday, June 17th will be given a dividend of $0.31 per share on Friday, June 24th. This represents a $1.24 annualized dividend and a dividend yield of 2.56%. The ex-dividend date is Thursday, June 16th.
View AMERISAFE's dividend history

Is AMERISAFE a good dividend stock?

AMERISAFE pays an annual dividend of $1.24 per share and currently has a dividend yield of 2.58%. AMERISAFE has been increasing its dividend for 9 consecutive years, indicating the company has a new, but growing committment to grow its dividend. The dividend payout ratio of AMERISAFE is 37.69%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, AMERISAFE will have a dividend payout ratio of 51.03% next year. This indicates that AMERISAFE will be able to sustain or increase its dividend.
View AMERISAFE's dividend history.

What price target have analysts set for AMSF?

2 equities research analysts have issued 12 month target prices for AMERISAFE's shares. Their forecasts range from $50.00 to $70.00. On average, they expect AMERISAFE's share price to reach $60.00 in the next twelve months. This suggests a possible upside of 23.7% from the stock's current price.
View analysts' price targets for AMERISAFE
or view top-rated stocks among Wall Street analysts.

Who are AMERISAFE's key executives?
AMERISAFE's management team includes the following people:
What is Janelle Frost's approval rating as AMERISAFE's CEO?

18 employees have rated AMERISAFE CEO Janelle Frost on Glassdoor.com. Janelle Frost has an approval rating of 79% among AMERISAFE's employees.

What other stocks do shareholders of AMERISAFE own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AMERISAFE investors own include Rollins (ROL), BioDelivery Sciences International (BDSI), Cronos Group (CRON), Quotient Technology (QUOT), Dominion Energy (D), AT&T (T), Bristol-Myers Squibb (BMY), CenterPoint Energy (CNP), Invesco (IVZ) and Altria Group (MO).

What is AMERISAFE's stock symbol?

AMERISAFE trades on the NASDAQ under the ticker symbol "AMSF."

Who are AMERISAFE's major shareholders?

AMERISAFE's stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (16.24%), Neuberger Berman Group LLC (7.36%), Victory Capital Management Inc. (7.02%), Vanguard Group Inc. (6.75%), State Street Corp (3.72%) and Dimensional Fund Advisors LP (3.29%). Company insiders that own AMERISAFE stock include Andrew B Mccray, G Janelle Frost, Kathryn Housh Shirley, Kevin T Hogan, Neal Andrew Fuller, Philip A Garcia, Philip A Garcia, Sean Traynor and Vincent J Gagliano.
View institutional ownership trends for AMERISAFE

Which institutional investors are selling AMERISAFE stock?

AMSF stock was sold by a variety of institutional investors in the last quarter, including Robeco Institutional Asset Management B.V., Ceredex Value Advisors LLC, Neuberger Berman Group LLC, Invesco Ltd., Assenagon Asset Management S.A., Royal Bank of Canada, Aviva PLC, and Royce & Associates LP. Company insiders that have sold AMERISAFE company stock in the last year include G Janelle Frost, Kathryn Housh Shirley, Neal Andrew Fuller, and Vincent J Gagliano.
View insider buying and selling activity for AMERISAFE
or view top insider-selling stocks.

Which institutional investors are buying AMERISAFE stock?

AMSF stock was acquired by a variety of institutional investors in the last quarter, including Westwood Holdings Group Inc., New South Capital Management Inc., Eaton Vance Management, Healthcare of Ontario Pension Plan Trust Fund, Vanguard Group Inc., Commonwealth Equity Services LLC, State Street Corp, and American Century Companies Inc.. Company insiders that have bought AMERISAFE stock in the last two years include Philip A Garcia, and Sean Traynor.
View insider buying and selling activity for AMERISAFE
or or view top insider-buying stocks.

How do I buy shares of AMERISAFE?

Shares of AMSF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is AMERISAFE's stock price today?

One share of AMSF stock can currently be purchased for approximately $48.51.

How much money does AMERISAFE make?

AMERISAFE has a market capitalization of $937.21 million and generates $315.93 million in revenue each year. The insurance provider earns $65.76 million in net income (profit) each year or $3.289990 on an earnings per share basis.

How many employees does AMERISAFE have?

AMERISAFE employs 371 workers across the globe.

When was AMERISAFE founded?

AMERISAFE was founded in 1985.

What is AMERISAFE's official website?

The official website for AMERISAFE is www.amerisafe.com.

How can I contact AMERISAFE?

AMERISAFE's mailing address is 2301 HIGHWAY 190 WEST, DERIDDER LA, 70634. The insurance provider can be reached via phone at (337) 463-9052, via email at [email protected], or via fax at 800-450-1091.

This page was last updated on 5/25/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.